- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 515/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patent holdings for IPC class C07D 515/00
Total number of patents in this class: 60
10-year publication summary
|
3
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1836 |
3 |
| SpecGx LLC | 186 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Wyeth LLC | 607 |
2 |
| AbbVie Deutschland GmbH & Co. KG | 258 |
2 |
| Astellas Pharma Inc. | 1044 |
2 |
| Exonhit Therapeutics SA | 18 |
2 |
| Progenics Pharmaceuticals, Inc. | 124 |
2 |
| Glaxo Group Limited | 4375 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Pfizer Inc. | 3386 |
1 |
| Merck Patent GmbH | 5728 |
1 |
| Allergan, Inc. | 2167 |
1 |
| Bayer Cropscience AG | 1844 |
1 |
| Merck Sharp & Dohme B.V. | 913 |
1 |
| Nitto Denko Corporation | 8536 |
1 |
| The Trustees of the University of Pennsylvania | 4415 |
1 |
| Takeda Pharmaceutical Company Limited | 2712 |
1 |
| University of South Florida | 1876 |
1 |
| AC Immune S.A. | 267 |
1 |
| Other owners | 30 |